Skip to main content
SpringerLink
Log in

Human Immunodeficiency Virus Infection

  • Chapter
Nutrition and Health in Developing Countries

Part of the book series: Nutrition and Health Series ((NH))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. UNAIDS. AIDS epidemic update: 2006. Geneva: World Health Organization, 2006.

    Google Scholar 

  2. Gottlieb MS, Schroff R, Schanker HM, et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl JMed 1981;305:1425–1431.

    CAS  Google Scholar 

  3. Masur H, Michelis MA, Greene JB, et al. An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N Engl J Med 1981;305:1431–1438.

    CAS  Google Scholar 

  4. Siegal FP, Lopez C, Hammer GS, et al. Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med 1981;305:1439–1444.

    CAS  Google Scholar 

  5. Centers for Disease Control and Prevention. Update on acquired immune deficiency syndrome (AIDS)-United States. MMWR Morb Mortal Wkly Rep 1982;31:507–508, 513–514.

    Google Scholar 

  6. Centers for Disease Control and Prevention. Pneumocystis carinii pneumonia among persons with hemophilia A. MMWR Morb Mortal Wkly Rep 1982;31:365–367.

    Google Scholar 

  7. Centers for Disease Control and Prevention. Unexplained immunodeficiency and opportunistic infections in infants—New York, New Jersey, California. MMWR Morb Mortal Wkly Rep 1982;31:665–667.

    Google Scholar 

  8. Centers for Disease Control and Prevention. Acquired immune deficiency syndrome (AIDS): precautions for clinical and laboratory staffs. MMWR Morb Mortal Wkly Rep 1982;31:577–580.

    Google Scholar 

  9. Barre-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983;220:868–871.

    CAS  Google Scholar 

  10. Gallo RC, Salahuddin SZ, Popovic M, et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 1984;224:500–503.

    CAS  Google Scholar 

  11. Popovic M, Sarngadharan MG, Read E, Gallo RC. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 1984;224:497–500.

    CAS  Google Scholar 

  12. Brun-Vezinet F, Rouzioux C, Barre-Sinoussi F, et al. Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome. Lancet 1984;1:1253–1256.

    CAS  Google Scholar 

  13. Sarngadharan MG, Popovic M, Bruch L, Schupbach J, Gallo RC. Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science 1984;224:506–508.

    CAS  Google Scholar 

  14. Serwadda D, Mugerwa RD, Sewankambo NK, et al. Slim disease: a new disease in Uganda and its association with HTLV-III infection. Lancet 1985;2:849–852.

    CAS  Google Scholar 

  15. Fischl MA, Richman DD, Grieco MH, et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med 1987;317:185–191.

    CAS  Google Scholar 

  16. Fischl MA, Dickinson GM, La Voie L. Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS. JAMA 1988;259:1185–1189.

    CAS  Google Scholar 

  17. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. NEngl J Med 1994;331:1173–1180.

    CAS  Google Scholar 

  18. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999;354:795–802.

    CAS  Google Scholar 

  19. UNAIDS. Report on the global AIDS epidemic. 2006. Available at: http://www.unaids.org/en/HTV_data/2006GlobalReport/default.asp.

  20. UNAIDS. AIDS epidemic update: 1998. Geneva: World Health Organization, 1998.

    Google Scholar 

  21. UNAIDS. AIDS epidemic update: 2004. Geneva: World Health Organization, 2004.

    Google Scholar 

  22. Celentano DD, Nelson KE, Lyles CM, et al. Decreasing incidence of HIV and sexually transmitted diseases in young Thai men: evidence for success of the HTV/AIDS control and prevention program. Aids 1998;12:F29–F36.

    CAS  Google Scholar 

  23. Kapiga SH, Lyamuya EF, Lwihula GK, Hunter DJ. The incidence of HIV infection among women using family planning methods in Dar es Salaam, Tanzania. Aids 1998;12:75–84.

    CAS  Google Scholar 

  24. Gregson S, Machekano R, Donnelly CA, Mbizvo MT, Anderson RM, Katzenstein DA. Estimating HIV incidence from age-specific prevalence data: comparison with concurrent cohort estimates in a study of male factory workers, Harare, Zimbabwe. Aids 1998;12:2049–2058.

    CAS  Google Scholar 

  25. Quigley MA, Kamali A, Kinsman J, et al. The impact of attending a behavioural intervention on HIV incidence in Masaka, Uganda. AIDS 2004;18:2055–2063.

    Google Scholar 

  26. Krai AH, Page-Shafer K, Edlin BR, et al. Persistent HTV incidence among injection drug users in San Francisco during the 1990s: results of five studies. J Acquir Immune Defic Syndr 2004;37:1667–1669.

    Google Scholar 

  27. Detels R, English P, Visscher BR, et al. Seroconversion, sexual activity, and condom use among 2,915 HTV seronegative men followed for up to 2 years. J Acquir Immune Defic Syndr 1989;2:77–83.

    CAS  Google Scholar 

  28. Holmberg SD, Horsburgh CR Jr, Ward JW, Jaffe HW. Biologic factors in the sexual transmission of human immunodeficiency virus. J Infect Dis 1989; 160:116–125.

    CAS  Google Scholar 

  29. Plummer FA, Simonsen JN, Cameron DW, et al. Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis 1991;163:233–239.

    CAS  Google Scholar 

  30. Cameron DW, Simonsen JN, D'Costa LJ, et al. Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet 1989;2:403–407.

    CAS  Google Scholar 

  31. Bongaarts J, Reining P, Way P, Conant F. The relationship between male circumcision and HIV infection in African populations. Aids 1989;3:373–377.

    CAS  Google Scholar 

  32. Dallabetta GA, Miotti PG, Chiphangwi JD, Liomba G, Canner JK, Saah AJ. Traditional vaginal agents: use and association with HTV infection in Malawian women. Aids 1995;9:293–297.

    CAS  Google Scholar 

  33. European Study Group on Heterosexual Transmission of HTV. Comparison of female to male and male to female transmission of HIV in 563 stable couples. BMJ 1992;304:809–813.

    Google Scholar 

  34. Dulioust E, Tachet A, De Almeida M, et al. Detection of HTV-1 in seminal plasma and seminal cells of HTV-1 seropositive men. J Reprod Immunol 1998;41:27–40.

    CAS  Google Scholar 

  35. Mostad SB, Jackson S, Overbaugh J, et al. Cervical and vaginal shedding of human immunodeficiency virus type 1-infected cells throughout the menstrual cycle. J Infect Dis 1998;178:983–991.

    CAS  Google Scholar 

  36. Italian Multicentre Study. Epidemiology, clinical features, and prognostic factors of paediatric HIV infection. Lancet 1988;2:1043–1046.

    Google Scholar 

  37. Goedert JJ, Mendez H, Drummond JE, et al. Mother-to-infant transmission of human immunodeficiency virus type 1: association with prematurity or low anti-gpl20. Lancet 1989;2:1351–1354.

    CAS  Google Scholar 

  38. Ryder RW, Nsa W, Hassig SE, et al. Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaire. N Engl J Med 1989;320:1637–1642.

    CAS  Google Scholar 

  39. European Collaborative Study. Risk factors for mother-to-child transmission of HTV-1. Lancet 1992;339:1007–1012.

    Google Scholar 

  40. Dunn DT, Newell ML, Ades AE, Peckham CS. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet 1992;340:585–588.

    CAS  Google Scholar 

  41. Landesman SH, Kalish LA, Burns DN, et al. Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study. N Engl J Med 1996;334:1617–1623.

    CAS  Google Scholar 

  42. Newell ML. Mechanisms and timing of mother-to-child transmission of HTV-1. AIDS 1998;12:831–837.

    CAS  Google Scholar 

  43. St Louis ME, Kamenga M, Brown C, et al. Risk for perinatal HTV-1 transmission according to maternal immunologic, virologic, and placental factors. JAMA 1993;269:2853–2859.

    CAS  Google Scholar 

  44. Villamor E, Saathoff E, Msamanga G, O'Brien ME, Manji K, Fawzi WW. Wasting during pregnancy increases the risk of mother-to-child HTV-1 transmission. J Acquir Immune Defic Syndr 2005;38:622–626.

    Google Scholar 

  45. Li HC, Biggar RJ, Miley WJ, et al. Provirus load in breast milk and risk of mother-to-child transmission of human T lymphotropic virus type I. J Infect Dis 2004; 190:1275–1278.

    Google Scholar 

  46. Rousseau CM, Nduati RW, Richardson BA, et al. Longitudinal analysis of human immunodeficiency virus type 1 RNA in breast milk and of its relationship to infant infection and maternal disease. J Infect Dis 2003;187:741–747.

    Google Scholar 

  47. Koulinska IN, Villamor E, Chaplin B, et al. Transmission of cell-free and cell-associated HTV-1 through breast-feeding. J Acquir Immune Defic Syndr 2006;41:93–99.

    Google Scholar 

  48. Semba RD, Kumwenda N, Hoover DR, et al. Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis 1995;8:506–510.

    Google Scholar 

  49. The Working Group on Mother-To-Child Transmission of HIV. Rates of mother-to-child transmission of HTV-1 in Africa, America, and Europe: results from 13 perinatal studies. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8:506–510.

    Google Scholar 

  50. Leroy V, Newell ML, Dabis F, et al. International multicentre pooled analysis of late postnatal mother-to-child transmission of HTV-1 infection. Ghent International Working Group on Mother-to-Child Transmission of HIV. Lancet 1998;352:597–600.

    CAS  Google Scholar 

  51. Miotti PG, Taha TE, Kumwenda NI, et al. HIV transmission through breastfeeding: a study in Malawi. JAMA 1999;282:744–749.

    CAS  Google Scholar 

  52. Fawzi W, Msamanga G, Spiegelman D, et al. Transmission of HTV-1 through breastfeeding among women in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr 2002;31:331–338.

    Google Scholar 

  53. Coutsoudis A, Dabis F, Fawzi W, et al. Late postnatal transmission of HTV-1 in breast-fed children: an individual patient data meta-analysis. J Infect Dis 2004;189:2154–2166.

    Google Scholar 

  54. Shaffer N, Chuachoowong R, Mock PA, et al. Short-course zidovudine for perinatal HTV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet 1999;353:773–780.

    CAS  Google Scholar 

  55. Wiktor SZ, Ekpini E, Karon JM, et al. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'lvoire: a randomised trial. Lancet 1999;353:781–785.

    CAS  Google Scholar 

  56. Dabis F, Msellati P, Meda N, et al. Six-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Cote d'lvoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study Group. Diminution de la Transmission Mere-Enfant. Lancet 1999;353:786–792.

    CAS  Google Scholar 

  57. Chersich MF, Gray GE. Progress and emerging challenges in preventing mother-to-child transmission. Curr Infect Dis Rep 2005;7:393–400.

    Google Scholar 

  58. Lackritz EM. Prevention of HIV transmission by blood transfusion in the developing world: achievements and continuing challenges. Aids 1998;12(suppl A):S81–S86.

    Google Scholar 

  59. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HTV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167–1170.

    CAS  Google Scholar 

  60. Stein DS, Korvick JA, Vermund SH. CD4+ lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review. J Infect Dis 1992; 165:352–363.

    CAS  Google Scholar 

  61. Centers for Disease Control and Prevention. 1993 revised classification system for HTV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992;41:1–19.

    Google Scholar 

  62. Redfield RR, Wright DC, Tramont EC. The Walter Reed staging classification for HTLV-III/LAV infection. N Engl J Med 1986;314:131–132.

    CAS  Google Scholar 

  63. World Health Organization. WHO case definitions of HTV for surveillance and revised clinical staging and immunological classification of HTV-related disease in adults and children. 2006. Available at: http://www.who.int/entity/hiv/pub/guidelines/HIVstagingl50307.pdf.

  64. Bollinger RC, Brookmeyer RS, Mehendale SM, et al. Risk factors and clinical presentation of acute primary HTV infection in India. JAMA 1997;278:2085–2089.

    CAS  Google Scholar 

  65. Mellors JW, Kingsley LA, Rinaldo CR Jr, et al. Quantitation of HTV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995; 122:573–579.

    CAS  Google Scholar 

  66. Koopman JS, Jacquez JA, Welch GW, et al. The role of early HTV infection in the spread of HIV through populations. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14:249–258.

    CAS  Google Scholar 

  67. Pantaleo G, Graziosi C, Fauci AS. New concepts in the immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 1993;328:327–335.

    CAS  Google Scholar 

  68. Tschachler E, Bergstresser PR, Stingl G. HTV-related skin diseases. Lancet 1996;348:659–663.

    CAS  Google Scholar 

  69. Miller WC, Thielman NM, Swai N, et al. Diagnosis and screening of HTV/AIDS using clinical criteria in Tanzanian adults. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:408–414.

    CAS  Google Scholar 

  70. Moosa MY, Coovadia YM. Cryptococcal meningitis in Durban, South Africa: a comparison of clinical features, laboratory findings, and outcome for human immunodeficiency virus (HlV)-positive and HTV-negative patients. Clin Infect Dis 1997;24:131–134.

    CAS  Google Scholar 

  71. Rogers MF, Caldwell MB, Gwinn ML, Simonds RJ. Epidemiology of pediatric human immunodeficiency virus infection in the United States. Acta Paediatr Suppl 1994;400:5–7.

    CAS  Google Scholar 

  72. Marum L, Bagenda D, Guay LA, et al. Three-year mortality in a cohort of HIV-1-infected and -unin-fected Ugandan children. Eleventh International Conference on AIDS and STDs; Vancouver; July 1996. Abstract WeB312.

    Google Scholar 

  73. Taha TE, Kumwenda NI, Broadhead RL, et al. Mortality after the first year of life among human immunodeficiency virus type 1-infected and uninfected children. Pediatr Infect Dis J 1999;18:689–694.

    CAS  Google Scholar 

  74. Kuhn L, Steketee RW, Weedon J, et al. Distinct risk factors for intrauterine and intrapartum human immunodeficiency virus transmission and consequences for disease progression in infected children. Perinatal AIDS Collaborative Transmission Study. J Infect Dis 1999; 179:52–58.

    CAS  Google Scholar 

  75. Mayaux MJ, Burgard M, Teglas JP, et al. Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. The French Pediatric HTV Infection Study Group. JAMA 1996;275:606–610.

    CAS  Google Scholar 

  76. Mofenson LM, Korelitz J, Meyer WA 3rd, et al. The relationship between serum human immunodeficiency virus type 1 (HTV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group. J Infect Dis 1997;175:1029–1038.

    CAS  Google Scholar 

  77. De Rossi A, Ometto L, Masiero S, Zanchetta M, Chieco-Bianchi L. Viral phenotype in mother-to-child HTV-l transmission and disease progression of vertically acquired HIV-1 infection. Acta Paediatr Suppl 1997;421:22–28.

    Google Scholar 

  78. Kiepiela P, Leslie AJ, Honeyborne I, et al. Dominant influence of HLA-B in mediating the potential co-evolution of HTV and HLA. Nature 2004;432:769–774.

    CAS  Google Scholar 

  79. Mummidi S, Ahuja SS, Gonzalez E, et al. Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HTV-l disease progression. Nat Med 1998;4:786–793.

    CAS  Google Scholar 

  80. Vallat AV, De Girolami U, He J, et al. Localization of HIV-1 co-receptors CCR5 and CXCR4 in the brain of children with AIDS. Am J Pathol 1998;152:167–178.

    CAS  Google Scholar 

  81. Misrahi M, Teglas JP, N'Go N, et al. CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children. French Pediatric HTV Infection Study Group. JAMA 1998;279:277–280.

    CAS  Google Scholar 

  82. Thea DM, St Louis ME, Atido U, et al. A prospective study of diarrhea and HTV-l infection among 429 Zairian infants. N Engl J Med 1993;329:1696–1702.

    CAS  Google Scholar 

  83. Berger EA. HIV entry and tropism: the chemokine receptor connection. AIDS 1997;ll(suppl A): 03–6110.

    Google Scholar 

  84. Borrow P, Lewicki H, Hahn BH, Shaw GM, Oldstone MB. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994;68:6103–6110.

    CAS  Google Scholar 

  85. Munoz A, Kirby AJ, He YD, et al. Long-term survivors with HIV-1 infection: incubation period and longitudinal patterns of CD4+ lymphocytes. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8:496–505.

    CAS  Google Scholar 

  86. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HTV-l infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996;273:1856–1862.

    CAS  Google Scholar 

  87. Keusch GT, Farthing MJ. Nutritional aspects of AIDS. Annu Rev Nutr 1990; 10:475–501.

    CAS  Google Scholar 

  88. Semba RD, Caiaffa WT, Graham NM, Cohn S, Vlahov D. Vitamin A deficiency and wasting as predictors of mortality in human immunodeficiency virus-infected injection drug users. J Infect Dis 1995;171:1196–1202.

    CAS  Google Scholar 

  89. Tang AM, Graham NM, Semba RD, Saah AJ. Association between serum vitamin A and E levels and HTV-1 disease progression. Aids 1997;ll:613–620.

    Google Scholar 

  90. Tang AM, Graham NM, Chandra RK, Saah AJ. Low serum vitamin B-12 concentrations are associated with faster human immunodeficiency virus type 1 (HIV-1) disease progression. J Nutr 1997;127:345–351.

    CAS  Google Scholar 

  91. Baeten JM, Richardson BA, Bankson DD, et al. Use of serum retinol-binding protein for prediction of vitamin A deficiency: effects of HTV-1 infection, protein malnutrition, and the acute phase response. Am J Clin Nutr 2004;79:218–225.

    CAS  Google Scholar 

  92. Abrams B, Duncan D, Hertz-Picciotto I. A prospective study of dietary intake and acquired immune deficiency syndrome in HTV-seropositive homosexual men. J Acquir Immune Defic Syndr 1993;6:949–958.

    CAS  Google Scholar 

  93. Tang AM, Graham NMH, Kirby AJ, McCall AD, Willett WC, Saah AJ. Dietary micronutrient intake and risk progression to acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus type 1 (HTV-l)-infected homosexual men. Am J Epidemiol 1993;138:1–15.

    Google Scholar 

  94. Tang AM, Graham NMH, Saah AJ. Effects of micronutrient intake on survival in human immunodeficiency virus type 1 infection. Am J Epidemiol 1996;143:1244–1256.

    CAS  Google Scholar 

  95. Kanter AS, Spencer DC, Steinberg MH, Soltysik R, Yarnold PR, Graham NM. Supplemental vitamin B and progression to AIDS and death in black South African patients infected with HTV. J Acquir Immune Defic Syndr 1999;21:252–253.

    CAS  Google Scholar 

  96. Coodley GO, Nelson HD, Loveless MO, Folk C. Beta-carotene in HIV infection. J Acquir Immune Defic Syndr 1993;6:272–276.

    CAS  Google Scholar 

  97. Nimmagadda AP, Burri BJ, Neidlinger T, O–Brien WA, Goetz MB. Effect of oral beta-carotene supplementation on plasma human immunodeficiency virus (HIV) RNA levels and CD4+ cell counts in HTV-infected patients. Clin Infect Dis 1998;27:1311–1313.

    CAS  Google Scholar 

  98. Kelly P, Musonda R, Kafwembe E, Kaetano L, Keane E, Farthing M. Micronutrient supplementation in the AIDS diarrhoea-wasting syndrome in Zambia: a randomized controlled trial. AIDS 1999;13:495–500.

    CAS  Google Scholar 

  99. Allard JP, Aghdassi E, Chau J, et al. Effects of vitamin E and C supplementation on oxidative stress and viral load in HTV-infected subjects. AIDS 1998;12:1653–1659.

    CAS  Google Scholar 

  100. Jiamton S, Pepin J, Suttent R, et al. A randomized trial of the impact of multiple micronutrient supplementation on mortality among HTV-infected individuals living in Bangkok. AIDS 2003; 17:2461–2469.

    CAS  Google Scholar 

  101. Fawzi WW, Msamanga GI, Spiegelman D, et al. A randomized trial of multivitamin supplements and HTV disease progression and mortality. N Engl J Med 2004;351:23–32.

    CAS  Google Scholar 

  102. Villamor E, Saathoff E, Manji K, Msamanga G, Hunter DJ, Fawzi WW. Vitamin supplements, socio-economic status, and morbidity events as predictors of wasting in HTV-infected women from Tanzania. Am J Clin Nutr 2005;82:857–865.

    CAS  Google Scholar 

  103. McClelland RS, Baeten JM, Overbaugh J, et al. Micronutrient supplementation increases genital tract shedding of HIV-1 in women: results of a randomized trial. J Acquir Immune Defic Syndr 2004;37:1657–1663.

    CAS  Google Scholar 

  104. Meydani SN, Barklund PM, Liu S, et al. Vitamin E supplementation enhances cell-mediated immunity in healthy elderly subjects. Am J Clin Nutr 1990;52:557–563.

    CAS  Google Scholar 

  105. Meydani S, Meydani M, Blumberg J, et al. Vitamin E supplementation and in vivo immune response in healthy elderly: a randomized controlled trial. JAMA 1997;277:1380–1386.

    CAS  Google Scholar 

  106. Pallast EG, Schouten EG, de Waart FG, et al. Effect of 50- and 100-mg vitamin E supplements on cellular immune function in noninstitutionalized elderly persons. Am J Clin Nutr 1999;69:1273–1281.

    CAS  Google Scholar 

  107. Kennes B, Dumont I, Brohee D, Hubert C, Neve P. Effect of vitamin C supplements on cell-mediated immunity in old people. Gerontology 1983;29:305–310.

    CAS  Google Scholar 

  108. Teichmann J, Stephan E, Discher T, et al. Changes in calciotropic hormones and biochemical markers of bone metabolism in patients with human immunodeficiency virus infection. Metabolism 2000;49: 1134–1139.

    CAS  Google Scholar 

  109. Teichmann J, Stephan E, Lange U, et al. Osteopenia in HTV-infected women prior to highly active antiretroviral therapy. J Infect 2003;46:221–227.

    CAS  Google Scholar 

  110. Haug C, Muller F, Aukrust P, Froland SS. Subnormal serum concentration of 1,25-vitamin D in human immunodeficiency virus infection: correlation with degree of immune deficiency and survival. J Infect Dis 1994;169:889–893.

    CAS  Google Scholar 

  111. Semba RD, Miotti PG, Chiphangwi JD, et al. Infant mortality and maternal vitamin A deficiency during human immunodeficiency virus infection. Clin Infect Dis 1995;21:966–972.

    CAS  Google Scholar 

  112. Semba RD, Miotti PG, Chiphangwi JD, et al. Maternal vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet 1994;343:1593–1597.

    CAS  Google Scholar 

  113. Graham NM, Munoz A, Bacellar H, Kingsley LA, Visscher BR, Phair JP. Clinical factors associated with weight loss related to infection with human immunodeficiency virus type 1 in the Multicenter AIDS Cohort Study. Am J Epidemiol 1993;137:439–446.

    CAS  Google Scholar 

  114. Kumwenda N, Miotti PG, Taha TE, et al. Antenatal vitamin A supplementation increases birth weight and decreases anemia among infants born to human immunodeficiency virus-infected women in Malawi. Clin Infect Dis 2002;35:618–624.

    CAS  Google Scholar 

  115. Coutsoudis A, Pillay K, Spooner E, Kuhn L, Coovadia HM. Randomized trial testing the effect of vitamin A supplementation on pregnancy outcomes and early mother-to-child HTV-1 transmission in Durban, South Africa. South African Vitamin A Study Group. Aids 1999;13:1517–1524.

    CAS  Google Scholar 

  116. Fawzi WW, Msamanga GI, Spiegelman D, et al. Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania. Lancet 1998;351:1477–1482.

    CAS  Google Scholar 

  117. Villamor E, Msamanga G, Spiegelman D, et al. Effect of multivitamin and vitamin A supplements on weight gain during pregnancy among HIV-1-infected women. Am J Clin Nutr 2002;76:1082–1090.

    CAS  Google Scholar 

  118. Fawzi WW, Msamanga G, Hunter D, et al. Randomized trial of vitamin supplements in relation to vertical transmission of HIV-1 in Tanzania. J Acquir Immune Defic Syndr 2000;23:246–254.

    CAS  Google Scholar 

  119. Fawzi WW, Msamanga GI, Hunter D, et al. Randomized trial of vitamin supplements in relation to transmission of HIV-1 through breastfeeding and early child mortality. Aids 2002; 16:1935–1944.

    CAS  Google Scholar 

  120. Fawzi WW, Msamanga GI, Wei R, et al. Effect of providing vitamin supplements to human immunodeficiency virus-infected, lactating mothers on the child's morbidity and CD4+ cell counts. Clin Infect Dis 2003;36:1053–1062.

    CAS  Google Scholar 

  121. Villamor E, Saathoff E, Bosch RJ, et al. Vitamin supplementation of HTV-infected women improves postnatal child growth. Am J Clin Nutr 2005;81:880–888.

    CAS  Google Scholar 

  122. Fawzi W, Msamanga G, Antelman G, et al. Effect of prenatal vitamin supplementation on lower-genital levels of HIV type 1 and interleukin type 1 beta at 36 weeks of gestation. Clin Infect Dis 2002;185:1187–1191.

    Google Scholar 

  123. Baeten JM, McClelland RS, Overbaugh J, et al. Vitamin A supplementation and human immunodeficiency virus type 1 shedding in women: results of a randomized clinical trial. J Infect Dis 2002;185:1187–1191.

    CAS  Google Scholar 

  124. Humphrey JH, Iliff PJ, Marinda ET, et al. Effects of a single large dose of vitamin A, given during the postpartum period to HIV-positive women and their infants, on child HIV infection, HIV-free survival, and mortality. J Infect Dis 2006;193:860–871.

    CAS  Google Scholar 

  125. MacDonald KS, Malonza I, Chen DK, et al. Vitamin A and risk of HTV-1 seroconversion among Kenyan men with genital ulcers. Aids 2001;15:635–639.

    CAS  Google Scholar 

  126. Coutsoudis A, Bobat RA, Coovadia HM, Kuhn L, Tsai WY, Stein ZA. The effects of vitamin A supplementation on the morbidity of children born to HIV-infected women. Am J Public Health 1999;18:127–133.

    Google Scholar 

  127. Fawzi WW, Mbise RL, Hertzmark E, et al. A randomized trial of vitamin A supplements in relation to mortality among human immunodeficiency virus-infected and uninfected children in Tanzania. Pediatr Infect Dis J 1999;18:127–133.

    CAS  Google Scholar 

  128. Fawzi WW, Mbise R, Spiegelman D, Fataki M, Hertzmark E, Ndossi G. Vitamin A supplements and diarrheal and respiratory tract infections among children in Dar es Salaam, Tanzania. J Pediatr 2000;137:660–667.

    CAS  Google Scholar 

  129. Villamor E, Mbise R, Spiegelman D, et al. Vitamin A supplements ameliorate the adverse effect of HTV-l, malaria, and diarrheal infections on child growth. Pediatrics 2002;109:E6.

    Google Scholar 

  130. Hanekom WA, Yogev R, Heald LM, Edwards KM, Hussey GD, Chadwick EG. Effect of vitamin A therapy on serologic responses and viral load changes after influenza vaccination in children infected with the human immunodeficiency virus. J Pediatr 2000;136:550–552.

    CAS  Google Scholar 

  131. Semba RD, Ndugwa C, Perry RT, et al. Effect of periodic vitamin A supplementation on mortality and morbidity of human immunodeficiency virus-infected children in Uganda: A controlled clinical trial. Nutrition 2005;21:25–31.

    CAS  Google Scholar 

  132. Villamor E, Fawzi WW. Effects of vitamin a supplementation on immune responses and correlation with clinical outcomes. Clin Microbiol Rev 2005;18:446–464.

    CAS  Google Scholar 

  133. Mehendale SM, Shepherd ME, Brookmeyer RS, et al. Low carotenoid concentration and the risk of HIV seroconversion in Pune, India. J Acquir Immune Defic Syndr 2001;26:352–359.

    CAS  Google Scholar 

  134. Moore PS, Allen S, Sowell AL, et al. Role of nutritional status and weight loss in HIV seroconversion among Rwandan women. J Acquir Immune Defic Syndr 1993;6:611–616.

    CAS  Google Scholar 

  135. Villamor E, Kapiga SH, Fawzi WW. Vitamin A serostatus and heterosexual transmission of HIV: case-control study in Tanzania and review of the evidence. Int J Vitam Nutr Res 2006;76:81–85.

    CAS  Google Scholar 

  136. Humphrey JH, Hargrove JW, Malaba LC, et al. HIV incidence among post-partum women in Zimbabwe: risk factors and the effect of vitamin A supplementation. AIDS 2006;20:1437–1446.

    CAS  Google Scholar 

  137. Baum MK, Shor-Posner G, Lai S, et al. High risk of HTV-related mortality is associated with selenium deficiency. J Acquir Immune Defic Syndr Hum Retrovirol 1997;15:370–374.

    CAS  Google Scholar 

  138. Kupka R, Msamanga GI, Spiegelman D, et al. Selenium status is associated with accelerated HTV disease progression among HIV-1-infected pregnant women in Tanzania. J Nutr 2004; 134:2556–2560.

    CAS  Google Scholar 

  139. Shor-Posner G, Miguez MJ, Pineda LM, et al. Impact of selenium status on the pathogenesis of myco-bacterial disease in HIV-1-infected drug users during the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2002;29:169–173.

    CAS  Google Scholar 

  140. Kupka R, Garland M, Msamanga G, Spiegelman D, Hunter D, Fawzi W. Selenium status, pregnancy outcomes, and mother-to-child transmission of HTV-1. J Acquir Immune Defic Syndr 2005;39:203–210.

    CAS  Google Scholar 

  141. Campa A, Shor-Posner G, Indacochea F, et al. Mortality risk in selenium-deficient HIV-positive children. J Acquir Immune Defic Syndr Hum Retrovirol 1999;20:508–513.

    CAS  Google Scholar 

  142. Kupka R, Msamanga GI, Spiegelman D, Rifai N, Hunter DJ, Fawzi WW. Selenium levels in relation to morbidity and mortality among children born to HTV-infected mothers. Eur J Clin Nutr 2005;59:1250–1258.

    CAS  Google Scholar 

  143. Delmas-Beauvieux MC, Peuchant E, Couchouron A, et al. The enzymatic antioxidant system in blood and glutathione status in human immunodeficiency virus (HTV)-infected patients: effects of supplementation with selenium or beta-carotene. Am J Clin Nutr 1996;64:101–107.

    CAS  Google Scholar 

  144. Look MP, Rockstroh JK, Rao GS, et al. Sodium selenite and N-acetylcysteine in antiretroviral-naive HIV-1-infected patients: a randomized, controlled pilot study. Eur J Clin Invest 1998;28:389–397.

    CAS  Google Scholar 

  145. Burbano X, Miguez-Burbano MJ, McCollister K, et al. Impact of a selenium chemoprevention clinical trial on hospital admissions of HIV-infected participants. HIV Clin Trials 2002;3:483–491.

    Google Scholar 

  146. Hurwitz BE, Klaus JR, Llabre MM, et al. Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial. Arch Intern Med 2007; 167:148–154.

    CAS  Google Scholar 

  147. Graham NM, Sorensen D, Odaka N, et al. Relationship of serum copper and zinc levels to HTV-1 seropositivity and progression to AIDS. J Acquir Immune Defic Syndr 1991;4:976–980.

    CAS  Google Scholar 

  148. Fawzi WW, Villamor E, Msamanga GI, et al. A trial of zinc supplements in relation to pregnancy outcomes, hematologic indicators, and T-cell counts among HTV-1 infected women in Tanzania. Am J Clin Nutr 2005;81:161–167.

    CAS  Google Scholar 

  149. Lind T, Lonnerdal B, Stenlund H, et al. A community-based randomized controlled trial of iron and zinc supplementation in Indonesian infants: interactions between iron and zinc. Am J Clin Nutr 2003;77:883–890.

    CAS  Google Scholar 

  150. Villamor E, Aboud S, Koulinska IN, et al. Zinc supplementation to HIV-1-infected pregnant women: effects on maternal anthropometry, viral load, and early mother-to-child transmission. Eur J Clin Nutr 2006;60:862–869.

    CAS  Google Scholar 

  151. Bobat R, Coovadia H, Stephen C, et al. Safety and efficacy of zinc supplementation for children with HTV-1 infection in South Africa: a randomised double-blind placebo-controlled trial. Lancet 2005;366:1862–1867.

    CAS  Google Scholar 

  152. Carcamo C, Hooton T, Weiss NS, et al. Randomized controlled trial of zinc supplementation for persistent diarrhea in adults with HTV-1 infection. J Acquir Immune Defic Syndr 2006;43:197–201.

    CAS  Google Scholar 

  153. O'Brien M E, Kupka R, Msamanga GI, Saathoff E, Hunter DJ, Fawzi WW. Anemia is an independent predictor of mortality and immunologic progression of disease among women with HIV in Tanzania. J Acquir Immune Defic Syndr 2005;40:219–225.

    Google Scholar 

  154. Belperio PS, Rhew DC. Prevalence and outcomes of anemia in individuals with human immunodeficiency virus: a systematic review of the literature. Am J Med 2004;116(suppl 7A):27S–43S.

    Google Scholar 

  155. Semba RD, Martin BK, Kempen JH, Thorne JE, Wu AW. The impact of anemia on energy and physical functioning in individuals with AIDS. Arch Intern Med 2005; 165:2229–2236.

    Google Scholar 

  156. Clark TD, Semba RD. Iron supplementation during human immunodeficiency virus infection: a double-edged sword? Med Hypotheses 2001;57:476–479.

    CAS  Google Scholar 

  157. Traore HN, Meyer D. The effect of iron overload on in vitro HTV-1 infection. J Clin Virol 2004;31(suppl l):92–98.

    Google Scholar 

  158. Olsen A, Mwaniki D, Krarup H, Friis H. Low-dose iron supplementation does not increase HTV-1 load. J Acquir Immune Defic Syndr 2004;36:637–638.

    CAS  Google Scholar 

  159. Drain PK, Kupka R, Mugusi F, Fawzi WW. Micronutrients in HIV-positive persons receiving highly active antiretroviral therapy. Am J Clin Nutr 2007;85:333–345.

    CAS  Google Scholar 

  160. Austin J, Singhal N, Voigt R, et al. A community randomized controlled clinical trial of mixed carot-enoids and micronutrient supplementation of patients with acquired immunodeficiency syndrome. Eur J Clin Nutr 2006;60:1266–1276.

    CAS  Google Scholar 

  161. Spada C, Treitinger A, Reis M, et al. An evaluation of antiretroviral therapy associated with alpha-tocopherol supplementation in HIV-infected patients. Clin Chem Lab Med 2002;40:456–459.

    CAS  Google Scholar 

  162. de Souza Junior O, Treitinger A, Baggio GL, et al. alpha-Tocopherol as an antiretroviral therapy supplement for HTV-1-infected patients for increased lymphocyte viability. Clin Chem Lab Med 2005;43:376–382.

    Google Scholar 

  163. Jaruga P, Jaruga B, Gackowski D, et al. Supplementation with antioxidant vitamins prevents oxidative modification of DNA in lymphocytes of HIV-infected patients. Free Radic Bid Med 2002;32:414–420.

    CAS  Google Scholar 

  164. Kaiser JD, Campa AM, Ondercin JP, Leoung GS, Pless RF, Baum MK. Micronutrient supplementation increases CD4 count in HIV-infected individuals on highly active antiretroviral therapy: a prospective, double-blinded, placebo-controlled trial. J Acquir Immune Defic Syndr 2006;42:523–528.

    CAS  Google Scholar 

  165. Jensen-Fangel S, Justesen US, Black FT, Pedersen C, Obel N. The use of calcium carbonate in nelfina-vir-associated diarrhoea in HTV-1-infected patients. HIV Med 2003;4:48–52.

    CAS  Google Scholar 

  166. Jeffery BS, Webber L, Mokhondo KR, Erasmus D. Determination of the effectiveness of inactivation of human immunodeficiency virus by Pretoria pasteurization. J Trop Pediatr 2001;47:345–349.

    CAS  Google Scholar 

  167. Coutsoudis A, Pillay K, Spooner E, Coovadia HM, Pembrey L, Newell ML. Morbidity in children born to women infected with human immunodeficiency virus in South Africa: does mode of feeding matter? Acta Paediatr 2003;92:890–895.

    CAS  Google Scholar 

  168. Iliff PJ, Piwoz EG, Tavengwa NV, et al. Early exclusive breastfeeding reduces the risk of postnatal HTV-1 transmission and increases HIV-free survival. AIDS 2005;19:699–708.

    Google Scholar 

  169. Coovadia HM, Rollins NC, Bland RM, et al. Mother-to-child transmission of HTV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study. Lancet 2007;369:1107–1116.

    Google Scholar 

  170. Jackson JB, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HTV-1 in Kampala, Uganda: 18-month follow-up of the HTVNET 012 randomised trial. Lancet 2003;362:859–868.

    CAS  Google Scholar 

  171. Thiorl, Lockman S, SmeatonLM, et al. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. JAMA 2006;296:794–805.

    CAS  Google Scholar 

  172. Nduati R, Richardson BA, John G, et al. Effect of breastfeeding on mortality among HTV-1 infected women: a randomised trial. Lancet 2001;357:1651–1655.

    CAS  Google Scholar 

  173. Coutsoudis A, Coovadia H, Pillay K, Kuhn L. Are HTV-infected women who breastfeed at increased risk of mortality? AIDS 2001; 15:653–655.

    CAS  Google Scholar 

  174. Sedgh G, Spiegelman D, Larsen U, Msamanga G, Fawzi WW. Breastfeeding and maternal HTV-1 disease progression and mortality. AIDS 2004;18:1043–1049.

    Google Scholar 

  175. Taha TE, Kumwenda NI, Hoover DR, et al. The impact of breastfeeding on the health of HIV-positive mothers and their children in sub-Saharan Africa. Bull World Health Organ 2006;84:546–554.

    Google Scholar 

  176. World Health Organization. WHO HIV and infant feeding technical consultation. Consensus statement. 2006. Available at: http://www.who.int/child-adolescent-health/New_Publications/NUTRI-TION/consensus_statement.pdf.

  177. Kotler DP, Tierney AR, Wang J, Pierson RNJ. Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 1989;50:444–447.

    CAS  Google Scholar 

  178. Suttmann U, Ockenga J, Selberg O, Hoogestraat L, Deicher H, Muller MJ. Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus-infected outpatients. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18:80–85.

    Google Scholar 

  179. Wheeler DA, Gibert CL, Launer CA, et al. Weight loss as a predictor of survival and disease progression in HIV infection. Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19:254–259.

    Google Scholar 

  180. Maas JJ, Dukers N, Krol A, et al. Body mass index course in asymptomatic HTV-infected homosexual men and the predictive value of a decrease of body mass index for progression to AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19:254–259.

    CAS  Google Scholar 

  181. Shor-Posner G, Campa A, Zhang G, et al. When obesity is desirable: a longitudinal study of the Miami HTV-1-infected drug abusers (MIDAS) cohort. J Acquir Immune Defic Syndr 2000;23:81–88.

    CAS  Google Scholar 

  182. Malvy E, Thiebaut R, Marimoutou C, Dabis F. Weight loss and body mass index as predictors of HTV disease progression to AIDS in adults. Aquitaine cohort, France, 1985–1997. J Am Coll Nutr 2001;20:609–615.

    CAS  Google Scholar 

  183. Jones CY, Hogan JW, Snyder B, et al. Overweight and human immunodeficiency virus (HTV) progression in women: associations HTV disease progression and changes in body mass index in women in the HIV epidemiology research study cohort. Clin Infect Dis 2003;37(suppl 2):S69–S80.

    Google Scholar 

  184. Ott M, Fischer H, Polat H, et al. Bioelectrical impedance analysis as a predictor of survival in patients with human immunodeficiency virus infection. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:20–25.

    CAS  Google Scholar 

  185. Schwenk A, Beisenherz A, Romer K, Kremer G, Salzberger B, Elia M. Phase angle from bioelectrical impedance analysis remains an independent predictive marker in HIV-infected patients in the era of highly active antiretroviral treatment. Am J Clin Nutr 2000;72:496–501.

    CAS  Google Scholar 

  186. Van Der Sande MA, Van Der Loeff MF, Aveika AA, et al. Body mass index at time of HTV diagnosis: a strong and independent predictor of survival. J Acquir Immune Defic Syndr 2004;37:1288–1294.

    Google Scholar 

  187. Villamor E, Dreyfuss ML, Baylin A, Msamanga G, Fawzi WW. Weight loss during pregnancy is associated with adverse pregnancy outcomes among HTV-1 infected women. J Nutr 2004; 134:1424–1431.

    CAS  Google Scholar 

  188. Berhane R, Bagenda D, Marum L, et al. Growth failure as a prognostic indicator of mortality in pediatric HTV infection. Pediatrics 1997;100:e7.

    CAS  Google Scholar 

  189. Lepage P, Msellati P, Hitimana DG, et al. Growth of human immunodeficiency type 1-infected and uninfected children: a prospective cohort study in Kigali, Rwanda, 1988 to 1993. Pediatr Infect Dis J 1996;15:479–485.

    CAS  Google Scholar 

  190. Villamor E, Misegades L, Fataki MR, Mbise RL, Fawzi WW. Child mortality in relation to HTV infection, nutritional status, and socio-economic background. Int J Epidemiol 2005;34:61–68.

    Google Scholar 

  191. Brocklehurst P, French R. The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis. Br J Obstet Gynaecol 1998;105:836–848.

    CAS  Google Scholar 

  192. Bulterys M, Chao A, Munyemana S, et al. Maternal human immunodeficiency virus 1 infection and intra-uterine growth: a prospective cohort study in Butare, Rwanda. Pediatr Infect Dis J 1994; 13:94–100.

    CAS  Google Scholar 

  193. Jason J, Gomperts E, Lawrence DN, et al. HIV and hemophilic children's growth. J Acquir Immune Defic Syndr 1989;2:277–282.

    CAS  Google Scholar 

  194. Villamor E, Fataki MR, Bosch RJ, Mbise RL, Fawzi WW. Human immunodeficiency virus infection, diarrheal disease and sociodemographic predictors of child growth. Acta Paediatr 2004;93:372–379.

    CAS  Google Scholar 

  195. Miller TL, Easley KA, Zhang W, et al. Maternal and infant factors associated with failure to thrive in children with vertically transmitted human immunodeficiency virus-1 infection: the prospective, P2C2 human immunodeficiency virus multicenter study. Pediatrics 2001;108:1287–1296.

    CAS  Google Scholar 

  196. Lindsey JC, Hughes MD, McKinney RE, et al. Treatment-mediated changes in human immunodeficiency virus (HTV) type 1 RNA and CD4 cell counts as predictors of weight growth failure, cognitive decline, and survival in HIV-infected children. J Infect Dis 2000;182:1385–1393.

    CAS  Google Scholar 

  197. Arpadi SM, Cuff PA, Kotler DP, et al. Growth velocity, fat-free mass and energy intake are inversely related to viral load in HIV-infected children. J Nutr 2000; 130:2498–2502.

    CAS  Google Scholar 

  198. McKinney RE Jr, Johnson GM, Stanley K, et al. A randomized study of combined zidovudine-lami-vudine versus didanosine monotherapy in children with symptomatic therapy-naive HTV-1 infection. The Pediatric AIDS Clinical Trials Group Protocol 300 Study Team. J Pediatr 1998;133:500–508.

    Google Scholar 

  199. Melikian G, Mmiro F, Ndugwa C, et al. Relation of vitamin A and carotenoid status to growth failure and mortality among Ugandan infants with human immunodeficiency virus. Nutrition 2001; 17:567–572.

    CAS  Google Scholar 

  200. Polsky B, Kotler D, Steinhart C. HTV-associated wasting in the HAART era: guidelines for assessment, diagnosis, and treatment. AIDS Patient Care STDS 2001;15:411–423.

    CAS  Google Scholar 

  201. WankeC, Kotler D. The approach to diagnosis and treatment of HTV wasting. J Acquir Immune Defic Syndr 2004;37:S284–S288.

    Google Scholar 

  202. Center for Disease Control and Prevention. 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Morb Mortal Wkly Rep 1994 ;43:1–19.

    Google Scholar 

  203. Godfried MH, van der Poll T, Jansen J, et al. Soluble receptors for tumour necrosis factor: a putative marker of disease progression in HTV infection. AIDS 1993;7:33–36.

    CAS  Google Scholar 

  204. Rimaniol AC, Zylberberg H, Zavala F, Viard JP. Inflammatory cytokines and inhibitors in HIV infection: correlation between interleukin-1 receptor antagonist and weight loss. AIDS 1996; 10:1349–1356.

    CAS  Google Scholar 

  205. Acharyya S, Ladner KJ, Nelsen LL, et al. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest 2004;114:370–378.

    CAS  Google Scholar 

  206. Tracey KJ, Beutler B, Lowry SF, et al. Shock and tissue injury induced by recombinant human cachectin. Science 1986;234:470–474.

    CAS  Google Scholar 

  207. Kotler DP. Human immunodeficiency virus-related wasting: malabsorption syndromes. Semin Oncol 1998;25:70–75.

    CAS  Google Scholar 

  208. Melchior JC, Salmon D, Rigaud D, et al. Resting energy expenditure is increased in stable, malnourished HIV-infected patients. Am J Clin Nutr 1991;53:437–441.

    CAS  Google Scholar 

  209. Grunfeld C, Pang M, Shimizu L, Shigenaga JK, Jensen P, Feingold KR. Resting energy expenditure, caloric intake, and short-term weight change in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Am J Clin Nutr 1992;55:455–460.

    CAS  Google Scholar 

  210. Bhasin S, Storer TW, Berman N, et al. Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J Clin Endocrinol Metab 1997;82:407–413.

    CAS  Google Scholar 

  211. Paton NI, Ng YM, Chee CB, Persaud C, Jackson AA. Effects of tuberculosis and HTV infection on whole-body protein metabolism during feeding, measured by the [15N]glycine method. Am J Clin Nutr 2003;78:319–325.

    CAS  Google Scholar 

  212. Villamor E, Msamanga G, Spiegelman D, Peterson KE, Antelman G, Fawzi WW. Pattern and predictors of weight gain during pregnancy among HTV-1 infected women from Tanzania. J Acquir Immune Defic Syndr 2003;32:560–569.

    Google Scholar 

  213. van Lettow M, Fawzi WW, Semba RD. Triple trouble: the role of malnutrition in tuberculosis and human immunodeficiency virus co-infection. Nutr Rev 2003;61:81–90.

    Google Scholar 

  214. Villamor E, Saathoff E, Mugusi F, Bosch RJ, Urassa W, Fawzi WW. Wasting and body composition of adults with pulmonary tuberculosis in relation to HIV-1 coinfection, socioeconomic status, and severity of tuberculosis. Eur J Clin Nutr 2005;60:163–171.

    Google Scholar 

  215. Laurichesse H, Tauveron I, Gourdon F, et al. Threonine and methionine are limiting amino acids for protein synthesis in patients with AIDS. J Nutr 1998;128:1342–1348.

    CAS  Google Scholar 

  216. Vorster HH, Kruger A, Margetts BM, et al. The nutritional status of asymptomatic HIV-infected Africans: directions for dietary intervention? Public Health Nutr 2004;7:1055–1064.

    Google Scholar 

  217. Moyle GJ, Schoelles K, Fahrbach K, et al. Efficacy of selected treatments of HTV wasting. J Acquir Immune Defic Syndr 2004;37:S262–S276.

    CAS  Google Scholar 

  218. Harriman GR, Smith PD, Home MK, et al. Vitamin B12 malabsorption in patients with acquired immunodeficiency syndrome. Arch Intern Med 1989;149:2039–2041.

    CAS  Google Scholar 

  219. Ehrenpreis ED, Carlson SJ, Boorstein HL, Craig RM. Malabsorption and deficiency of vitamin B12 in HIV-infected patients with chronic diarrhea. Dig Dis Sci 1994;39:2159–2162.

    CAS  Google Scholar 

  220. Jolly PE, Moon TD, Mitra AK, del Rosario GR, Blount S, Clemons TE. Vitamin A depletion in hospital and clinic patients with acquired immunodeficiency syndrome—a preliminary report. Nutr Res 1997;56:459–469.

    Google Scholar 

  221. Jordao Junior AA, Silveira S, Figueiredo JF, Vannucchi H. Urinary excretion and plasma vitamin E levels in patients with AIDS. Nutrition 1998;14:423–426.

    CAS  Google Scholar 

  222. Semba RD. Vitamin A and human immunodeficiency virus infection. Proc Nutr Soc 1997;56:459–469.

    CAS  Google Scholar 

  223. Phuapradit W, Chaturachinda K, Taneepanichskul S, Sirivarasry J, Khupulsup K, Lerdvuthisopon N. Serum vitamin A and beta-carotene levels in pregnant women infected with human immunodeficiency virus-1. Obstet Gynecol 1996;87:564–567.

    CAS  Google Scholar 

  224. Friis H, Gomo E, Koestel P, et al. HIV and other predictors of serum beta-carotene and retinol in pregnancy: a cross-sectional study in Zimbabwe. Am J Clin Nutr 2001;73:1058–1065.

    CAS  Google Scholar 

  225. Bogden JD, Baker H, Frank O, et al. Micronutrient status and human immunodeficiency virus (HTV) infection. Ann N Y Acad Sci 1990;587:189–195.

    CAS  Google Scholar 

  226. Beach RS, Mantero-Atienza E, Shor-Posner G, et al. Specific nutrient abnormalities in asymptomatic HTV-1 infection. AIDS 1992;6:701–708.

    CAS  Google Scholar 

  227. Baum MK, Shor-Posner G, Lu Y, et al. Micronutrients and HIV-1 disease progression. AIDS 1995;9:1051–1056.

    CAS  Google Scholar 

  228. Mastroiacovo P, Ajassa C, Berardelli G, et al. Antioxidant vitamins and immunodeficiency. Int J Vit Nutr Res 1991;6: 472–479.

    Google Scholar 

  229. Skurnick JH, Bogden JD, Baker H, et al. Micronutrient profiles in HTV-1-infected heterosexual adults. J Acquir Immune Defic Syndr Hum Retrovirol 1996;12:75–83.

    CAS  Google Scholar 

  230. Coodley G, Girard DE. Vitamins and minerals in HIV infection. J Gen Intern Med 1991;6:472–479.

    CAS  Google Scholar 

  231. Burkes RL, Cohen H, Krailo M, Sinow RM, Carmel R. Low serum cobalamin levels occur frequently in the acquired immune deficiency syndrome and related disorders. Eur J Haematol 1987;38:141–147.

    CAS  Google Scholar 

  232. Paltiel O, Falutz J, Veilleux M, Rosenblatt DS, Gordon K. Clinical correlates of subnormal vitamin B12 levels in patients infected with the human immunodeficiency virus. Am J Hematol 1995;49:318–322.

    CAS  Google Scholar 

  233. Friis H, Gomo E, Koestel P, et al. HTV and other predictors of serum folate, serum ferritin, and hemoglobin in pregnancy: a cross-sectional study in Zimbabwe. Am J Clin Nutr 2001;73:1066–1073.

    CAS  Google Scholar 

  234. Boudes P, Zittoun J, Sobel A. Folate, vitamin B12, and HTV infection. Lancet 1990;335:1401–1402.

    CAS  Google Scholar 

  235. Ullrich R, Schneider T, Heise W, et al. Serum carotene deficiency in HIV–infected patients. Berlin Diarrhoea/Wasting Syndrome Study Group. AIDS 1994;8:661–665.

    CAS  Google Scholar 

  236. Mueller BU, Tannenbaum S, Pizzo PA. Bone marrow aspirates and biopsies in children with human immunodeficiency virus infection. J Pediatr Hematol Oncol 1996;18:266–271.

    CAS  Google Scholar 

  237. Castaldo A, Tarallo L, Palomba E, et al. Iron deficiency and intestinal malabsorption in HIV disease. J Pediatr Gastroenterol Nutr 1996;22:359–363.

    CAS  Google Scholar 

  238. Koch J, Neal EA, Schlott MJ, et al. Zinc levels and infections in hospitalized patients with AIDS. Nutrition 1996; 12:515–518.

    CAS  Google Scholar 

  239. Dworkin BM, Rosenthal WS, Wormser GP, Weiss L. Selenium deficiency in the acquired immunodeficiency syndrome. JPEN J Parenter Enteral Nutr 1986; 10:405–407.

    CAS  Google Scholar 

  240. Mantero-Atienza E, Beach RS, Gavancho MC, Morgan R, Shor-Posner G, Fordyce-Baum MK. Selenium status of HIV-1 infected individuals. JPEN J Parenter Enteral Nutr 1991;15:693–694.

    CAS  Google Scholar 

  241. Cirelli A, Ciardi M, de Simone C, et al. Serum selenium concentration and disease progress in patients with HTV infection. Clin Biochem 1991;24:211–214.

    CAS  Google Scholar 

  242. Horsburgh CR Jr, Ou CY, Jason J, et al. Duration of human immunodeficiency virus infection before detection of antibody. Lancet 1989;2:637–640.

    Google Scholar 

  243. Biggar RJ, Miley W, Miotti P, et al. Blood collection on filter paper: a practical approach to sample collection for studies of perinatal HIV transmission. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:368–373.

    CAS  Google Scholar 

  244. Saracco A, Musicco M, Nicolosi A, et al. Man-to-woman sexual transmission of HIV: longitudinal study of 343 steady partners of infected men. J Acquir Immune Defic Syndr 1993;6:497–502.

    CAS  Google Scholar 

  245. Hanenberg RS, Rojanapithayakorn W, Kunasol P, Sokal DC. Impact of Thailand's HTV-control programme as indicated by the decline of sexually transmitted diseases. Lancet 1994;344:243–245.

    CAS  Google Scholar 

  246. de Vincenzi I. A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. European Study Group on Heterosexual Transmission of HTV. N Engl J Med 1994;331:341–346.

    Google Scholar 

  247. Laga M, Alary M, Nzila N, et al. Condom promotion, sexually transmitted diseases treatment, and declining incidence of HIV-1 infection in female Zairian sex workers. Lancet 1994;344:246–248.

    CAS  Google Scholar 

  248. Ghys PD, Fransen K, Diallo MO, et al. The associations between cervicovaginal HTV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Cote d'lvoire. AIDS1997;11:F85–F93.

    CAS  Google Scholar 

  249. Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995;346:530–536.

    CAS  Google Scholar 

  250. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial. PLoS Med 2005;2:e298.

    Google Scholar 

  251. Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 2007;369:657–666.

    Google Scholar 

  252. Bailey RC, Moses S, Parker CB, et al. Male circumcision for HTV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 2007;369:643–656.

    Google Scholar 

  253. Mandelbrot L, Le Chenadec J, Berrebi A, et al. Perinatal HIV-1 transmission: interaction between zid-ovudine prophylaxis and mode of delivery in the French Perinatal Cohort. JAMA 1998;280:55–60.

    CAS  Google Scholar 

  254. Leroy V, Sakarovitch C, Cortina-Borja M, et al. Is there a difference in the efficacy of peripartum antiret-roviral regimens in reducing mother-to-child transmission of HTV in Africa? Aids 2005;19:1865–1875.

    Google Scholar 

  255. Petra Study Team. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial. Lancet 2002;359:1178–1186.

    Google Scholar 

  256. Shapiro RL, Holland DT, Capparelli E, et al. Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment. J Infect Dis 2005; 192:720–7.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Nutrition and Epidemiology, Harvard School of Public Health, Boston, MA, USA

    Eduardo Villamor & Wafaie W. Fawzi

  2. Muhimbili University College of Medical Sciences, Dar-es-Salaam, Tanzania

    Karim Manji

Authors
  1. Eduardo Villamor
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karim Manji
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wafaie W. Fawzi
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Richard D. Semba MD, MPH

  2. Nutrition and HIV/AIDS Policy, United Nations World Food Programme, Rome, Italy

    Martin W. Bloem MD, PhD

  3. Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

    Martin W. Bloem MD, PhD

  4. Friedman School of Nutrition Science and Policy, Tufts University, Boston, MA, USA

    Martin W. Bloem MD, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Villamor, E., Manji, K., Fawzi, W.W. (2008). Human Immunodeficiency Virus Infection. In: Semba, R.D., Bloem, M.W., Piot, P. (eds) Nutrition and Health in Developing Countries. Nutrition and Health Series. Humana Press. https://doi.org/10.1007/978-1-59745-464-3_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-464-3_11

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-934115-24-4

  • Online ISBN: 978-1-59745-464-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation